Arimidex 1mg – Anastrozole for Breast Cancer

Arimidex 1mg, containing Anastrozole, is a non-steroidal aromatase inhibitor for hormone-sensitive breast cancer. It reduces estrogen production, fueling certain breast cancer cells.

Primary medical indications include adjuvant treatment, first-line advanced cancer, and sequential therapy. As an aromatase inhibitor, it blocks androgen conversion to estrogen in postmenopausal women.

Important treatment protocol and safety profile: Arimidex requires a prescription and medical supervision. Standard dosage is one 1mg tablet daily. Key side effects include bone health risks and osteoporosis.